ImaginAb Inc., a global biotechnology company focused on developing 89Zr crefmirlimab berdoxam imaging agent and radiopharmaceutical therapy (RPT) products, announced the signing of a...
Imaging Endpoints (IE) and ImaginAb announced that after collaborating for nearly a decade they have entered into a license agreement for IE to directly...
